Skip to main content
Literatur
1.
Zurück zum Zitat Thorp J Jr, Palacios S, Symons J, Simon J, Barbour K (2014) Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin. BJOG 121(11):1328–1331CrossRefPubMed Thorp J Jr, Palacios S, Symons J, Simon J, Barbour K (2014) Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin. BJOG 121(11):1328–1331CrossRefPubMed
2.
Zurück zum Zitat Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M Jr et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. J Sex Med 9(4):1074–1085PubMed Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M Jr et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. J Sex Med 9(4):1074–1085PubMed
3.
Zurück zum Zitat Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M Jr et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 9(3):793–804PubMed Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M Jr et al (2012) Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 9(3):793–804PubMed
4.
Zurück zum Zitat Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr et al (2013) Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 10(7):1807–1815PubMed Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr et al (2013) Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 10(7):1807–1815PubMed
5.
Zurück zum Zitat Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM, SUNFLOWER Study Investigators (2012) Open-label extension study of flibanserin in women with hypoactive sexual desire disorder. J Sex Med 9(12):3180–3188PubMed Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM, SUNFLOWER Study Investigators (2012) Open-label extension study of flibanserin in women with hypoactive sexual desire disorder. J Sex Med 9(12):3180–3188PubMed
6.
Zurück zum Zitat Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T et al (2011) Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. J Sex Med 8(11):3160–3172PubMed Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T et al (2011) Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. J Sex Med 8(11):3160–3172PubMed
7.
Zurück zum Zitat Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M Jr, Sand M (2014) Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause 21(6):633–640CrossRefPubMed Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M Jr, Sand M (2014) Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause 21(6):633–640CrossRefPubMed
Metadaten
Titel
Einfluss von Flibanserin auf die Libido
Wie gut ist die neue „Sex-Pille“ für Frauen?
verfasst von
PD Dr. P. Stute
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Gynäkologische Endokrinologie / Ausgabe 1/2016
Print ISSN: 1610-2894
Elektronische ISSN: 1610-2908
DOI
https://doi.org/10.1007/s10304-015-0041-3

Weitere Artikel der Ausgabe 1/2016

Gynäkologische Endokrinologie 1/2016 Zur Ausgabe

Einführung zum Thema

Endometriose – Update 2016

Medizin aktuell

ASRM 2015

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.